Bank of New York Mellon’s Lyra Therapeutics LYRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,432
| Closed | -$9.04K | – | 4192 |
|
|
2025
Q1 | $9.04K | Sell |
1,432
-87
| -6% | -$549 | ﹤0.01% | 4083 |
|
|
2024
Q4 | $15.7K | Hold |
1,519
| – | – | ﹤0.01% | 4082 |
|
|
2024
Q3 | $19.5K | Sell |
1,519
-29
| -2% | -$373 | ﹤0.01% | 4061 |
|
|
2024
Q2 | $21.4K | Buy |
+1,548
| New | +$21.4K | ﹤0.01% | 4073 |
|
|
2024
Q1 | – | Sell |
-372
| Closed | -$97.6K | – | 4243 |
|
|
2023
Q4 | $97.6K | Hold |
372
| – | – | ﹤0.01% | 4082 |
|
|
2023
Q3 | $72.8K | Buy |
+372
| New | +$72.8K | ﹤0.01% | 4119 |
|
|
2022
Q4 | – | Sell |
-390
| Closed | -$98K | – | 4522 |
|
|
2022
Q3 | $98K | Buy |
+390
| New | +$98K | ﹤0.01% | 4198 |
|
|
2021
Q2 | – | Sell |
-301
| Closed | -$174K | – | 4429 |
|
|
2021
Q1 | $174K | Sell |
301
-88
| -23% | -$50.9K | ﹤0.01% | 4086 |
|
|
2020
Q4 | $222K | Buy |
389
+76
| +24% | +$43.4K | ﹤0.01% | 3943 |
|
|
2020
Q3 | $175K | Buy |
313
+48
| +18% | +$26.8K | ﹤0.01% | 3873 |
|
|
2020
Q2 | $151K | Buy |
+265
| New | +$151K | ﹤0.01% | 3858 |
|